Both weight loss preparations are manufactured by Danish company Novo Nordisk.
The amount can be increased further if the eye disease has also led to a loss of income from work.
The decision is the first in a series, in total over 40 patients in Denmark have demanded compensation after being affected by Naion.
Studies have shown that the risk of developing the disease is about 1 in 10,000, but that it can double when people with type 2 diabetes are treated with Ozempic or similar drugs. The eye disease Naion can lead to vision loss.
